Innate Pharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 17, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	93	132	183	234	295	245
Market Cap Growth	-31.74%	-27.85%	-21.67%	-20.77%	20.59%	-38.25%
Enterprise Value	65	86	141	163	209	129
Last Close Price	1.01	1.58	2.22	2.96	3.66	3.11
PS Ratio	8.61	7.95	3.43	4.58	14.24	3.92
PB Ratio	21.16	18.11	4.07	4.87	3.27	1.75
P/TBV Ratio	21.16	18.11	4.10	5.02	5.56	2.49
EV/Sales Ratio	5.95	5.15	2.65	3.19	10.07	2.07
EV/EBITDA Ratio	-	-	-	-	-	10.86
EV/EBIT Ratio	-	-	-	-	-	133.87
Debt / Equity Ratio	5.25	3.51	0.77	0.78	0.41	0.12
Debt / EBITDA Ratio	-	-	-	-	-	1.33
Net Debt / Equity Ratio	-6.41	-5.63	-1.01	-1.09	-0.70	-0.85
Net Debt / EBITDA Ratio	0.66	0.99	6.16	4.93	1.75	-9.96
Net Debt / FCF Ratio	0.80	6.83	1.60	3.01	1.27	2.52
Asset Turnover	0.10	0.14	0.33	0.25	0.09	0.20
Quick Ratio	2.08	2.50	3.51	3.21	1.67	3.64
Current Ratio	2.21	2.60	3.73	3.38	1.73	3.81
Return on Equity (ROE)	-271.37%	-162.91%	-14.28%	-71.75%	-34.53%	-0.44%
Return on Assets (ROA)	-25.92%	-22.52%	-4.23%	-4.40%	-10.40%	0.19%
Return on Invested Capital (ROIC)	-	-	-	-122.70%	-173.03%	5.30%
Return on Capital Employed (ROCE)	-79.80%	-66.10%	-9.30%	-10.40%	-25.50%	0.40%
Earnings Yield	-42.32%	-30.93%	-3.58%	-22.02%	-15.02%	-23.41%
FCF Yield	-37.92%	-4.56%	-15.58%	-7.46%	-16.89%	-19.27%
Buyback Yield / Dilution	-4.15%	-0.74%	-1.02%	-0.12%	-0.77%	-17.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.